TNFSF9 and leukemia: The K562 leukemia cell line has been modified to express ligands associated with antigen presenting cells (CD64, CD86, and truncated CD19) along with 4-1BB Ligand (CD137L) and membrane-bound IL-21 (K562-mbIL21-41BBL).